Polyethylene Glycol 3350
Product Images NDC 0722-6920

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Polyethylene Glycol 3350 (NDC 0722-6920). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexgen Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

255 Gram Principal Display Panel (71508b14 3d59 408c B43c Aff2f47b8b3d 01)

255 Gram Principal Display Panel (71508b14 3d59 408c B43c Aff2f47b8b3d 01)
This is a description of a prescription laxative medication made by Nexgen Pharma. The medication contains Polyethylene Glycol 3350 NF and comes in a powder form for oral solution. The daily dose is 17 grams per day or as directed by the physician, and it should be taken by mixing with a cup of water, juice, soda, coffee, or tea until completely dissolved. The treatment may require 2 to 4 days to produce a bowel movement. The medication should be kept out of the reach of children and stored at 20°-25°C (68°-77°F). The medication is distributed by Breckenridge Pharmaceutical, Inc. located in Boca Raton, FL 33487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.